ArticleAntibody therapeutics2026

Application of a novel LC-MS-based proteomic workflow for host cell protein monitoring and risk control in biotherapeutics.

Xiaojuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.